184 related articles for article (PubMed ID: 25992751)
21. [Application of combined antibacterial preparations in the treatment of surgical intra-abdominal infections].
Nichitaĭlo ME; Bulik LM
Klin Khir; 2013 Jan; (1):37-9. PubMed ID: 23610943
[TBL] [Abstract][Full Text] [Related]
22. Editorial commentary: effectiveness or efficacy: which study to evaluate antibiotics in neonates?
Jacqz-Aigrain E
Clin Infect Dis; 2012 Dec; 55(11):1503-4. PubMed ID: 22955433
[No Abstract] [Full Text] [Related]
23. Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia.
Tellor B; Skrupky LP; Symons W; High E; Micek ST; Mazuski JE
Surg Infect (Larchmt); 2015 Dec; 16(6):785-93. PubMed ID: 26258265
[TBL] [Abstract][Full Text] [Related]
24. [Enhancing efficacy of the primary antibacterial therapy for intraabdominal infections].
Boĭko VV; Ivanova IuV
Klin Khir; 2012 Nov; (11):54-8. PubMed ID: 23272388
[TBL] [Abstract][Full Text] [Related]
25. Re: Septic shock and adequacy of early empiric antibiotics in the emergency department.
Schaeffer EM
J Urol; 2015 Apr; 193(4):1263-4. PubMed ID: 25890515
[No Abstract] [Full Text] [Related]
26. Clinical challenges and unmet needs in the management of complicated intra-abdominal infections.
Mazuski JE
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-49-69. PubMed ID: 23577497
[TBL] [Abstract][Full Text] [Related]
27. Comment on: Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching.
Grothe J; Sprute R; Cornely OA
J Antimicrob Chemother; 2022 Jul; 77(8):2308-2309. PubMed ID: 35325191
[No Abstract] [Full Text] [Related]
28. Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options.
Leone S; Stefani S; Venditti M; Grossi P; Colizza S; De Gasperi A; Scaglione F; Sganga G; Esposito S;
Int J Antimicrob Agents; 2011 Sep; 38(3):271-2. PubMed ID: 21782394
[No Abstract] [Full Text] [Related]
29. Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching-authors' response.
Geersing TH; Franssen EJF; Spronk PE; van Kan HJM; den Reijer M; van der Voort PHJ
J Antimicrob Chemother; 2022 Jul; 77(8):2309-2311. PubMed ID: 35781512
[No Abstract] [Full Text] [Related]
30. Changes in the aerobic faecal flora of patients treated with antibiotics for acute intra-abdominal infection.
Samuelsson A; Isaksson B; Chabok A; Jonasson J; Nilsson LE; Eriksson O; Hanberger H
Scand J Infect Dis; 2012 Nov; 44(11):820-7. PubMed ID: 22831634
[TBL] [Abstract][Full Text] [Related]
31. Sparing anti-pseudomonas antibiotics in intraabdominal infections.
Papagheorghe R; Angelescu N
Chirurgia (Bucur); 2012; 107(4):488-93. PubMed ID: 23025116
[TBL] [Abstract][Full Text] [Related]
32. Empiric antimicrobial treatment of intraabdominal sepsis.
Smith JM
N Z Med J; 1994 Oct; 107(988):422-3. PubMed ID: 7970337
[No Abstract] [Full Text] [Related]
33. Heart and systemic effects of statin pretreatment in a rat model of abdominal sepsis. Assessment by Tc99m-sestamibi biodistribition.
Macedo R; Javadi SM; Higuchi T; Carvalho MD; Medeiros Vde F; Azevedo ÍM; Lima FP; Medeiros AC
Acta Cir Bras; 2015 Jun; 30(6):388-93. PubMed ID: 26108026
[TBL] [Abstract][Full Text] [Related]
34. [Morphology of umbilical sepsis at different periods of antibiotic therapy in infants].
AFANAS'EVA VM
Pediatriia; 1962 Jan; 41():15-20. PubMed ID: 13859524
[No Abstract] [Full Text] [Related]
35. Ceftolozane/Tazobactam (Zerbaxa)--a new intravenous antibiotic.
Med Lett Drugs Ther; 2015 Mar; 57(1463):31-3. PubMed ID: 25719997
[No Abstract] [Full Text] [Related]
36. Is tigecycline drug of choice for cIAI and cSSTI?
Hosgor-Limoncu M
Int J Clin Pract; 2013 Jun; 67(6):492-3. PubMed ID: 23679901
[No Abstract] [Full Text] [Related]
37. Eravacycline for the treatment of patients with bacterial infections.
Thakare R; Dasgupta A; Chopra S
Drugs Today (Barc); 2018 Apr; 54(4):245-254. PubMed ID: 29869646
[TBL] [Abstract][Full Text] [Related]
38. Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Gergely Szabo B; Kadar B; Szidonia Lenart K; Dezsenyi B; Kunovszki P; Fried K; Kamotsay K; Nikolova R; Prinz G
Clin Microbiol Infect; 2016 Dec; 22(12):990-995. PubMed ID: 27599690
[TBL] [Abstract][Full Text] [Related]
39. Patients with Risk Factors for Complications Do Not Require Longer Antimicrobial Therapy for Complicated Intra-Abdominal Infection.
Rattan R; Allen CJ; Sawyer RG; Mazuski J; Duane TM; Askari R; Banton KL; Claridge JA; Coimbra R; Cuschieri J; Dellinger EP; Evans HL; Guidry CA; Miller PR; O'Neill PJ; Rotstein OD; West MA; Popovsky K; Namias N
Am Surg; 2016 Sep; 82(9):860-6. PubMed ID: 27670577
[TBL] [Abstract][Full Text] [Related]
40. Eravacycline for the treatment of intra-abdominal infections.
Bassetti M; Righi E
Expert Opin Investig Drugs; 2014 Nov; 23(11):1575-84. PubMed ID: 25251475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
